Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for ...

Eli Lilly's bimagrumab led to weight loss that was due almost entirely to fat reduction when combined with semaglutide, ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

Below are a few more promising studies of weight-loss drugs. Combining bimagrumab, an investigational human monoclonal ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, ...

Welcome back on the Daily Aviation for a new documentary video about the QF-16, a standard F-16 Fighting Falcon modified into ...

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic ...

Creative Biolabs recently rolled out a three-dimensional upgrade designed to make antibodies safer, more potent, and easier to develop. SHIRLEY, NY, UNITED STATES, June 18, 2025 /EINPresswire.com/ -- ...

Welcome back on the Daily Aviation for a new documentary video about the QF-16, a standard F-16 Fighting Falcon modified into a full-scale target drones for the US Air Force. Footage Credit: US Air ...

iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody. New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates (NHP) and ...

CHICAGO -- An investigational injectable that only requires dosing once every 4 weeks led to substantial weight loss in ...